申请人:Laboratorios Del. Dr. Esteve, S.A.
公开号:EP2149373A1
公开(公告)日:2010-02-03
The present invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, especially as agonists, identified by using a pharmacophore and a descriptor's profile filter as well as to pharmaceutical compositions comprising them. These compounds are useful in therapy in particular for the treatment and or prophylaxis of a disease in which 5-HT7 is involved, such as CNS disorders.
本发明涉及具有药理活性的化合物,特别是作为5-HT7受体激动剂,通过使用药效团和描述符的配置文件筛选识别,以及包含它们的药物组合物。这些化合物在治疗中特别有用,特别是用于治疗和/或预防涉及5-HT7的疾病,如中枢神经系统紊乱。